US cancer institute suspends trial

BMJ 1994; 308 doi: (Published 09 April 1994) Cite this as: BMJ 1994;308:936
  1. J Roberts

    The head of North America's biggest breast cancer study group has stepped aside at the insistence of the US National Cancer Institute. Dr Bernard Fisher, a professor of surgery at the University of Pittsburgh, was asked to resign his leadership of the national surgical adjuvant breast and bowel project, which has run more than 10 major treatment trials for breast cancer. He quickly announced that he would leave his post. In addition to seeking …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription